Researcher
Ashkan PIRMANI
- Keywords (Hasselt University):Biomedical sciences (incl. biochemistry)
- Disciplines (KU Leuven):Machine learning and decision making, Computational biomodelling and machine learning
- Disciplines (Hasselt University):Immunology not elsewhere classified
- See also: Ashkan Pirmani (KU Leuven)
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From16 Sep 2019 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From16 Sep 2019 → Today - Dynamical Systems, Signal Processing and Data Analytics (STADIUS) (Division)
Member
From17 Dec 2021 → Today - Immunology - Biochemistry (Research group)
Member
From16 Sep 2019 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From16 Sep 2019 → 31 Dec 2019
Projects
1 - 1 of 1
- Sub-Grant agreement Model between EMC and Hasselt University in the framework of the EHDEN consortiumFrom15 Feb 2021 → 31 Dec 2022Funding: Foreign public sponsor
Publications
1 - 9 of 9
- The Journey of Data Within a Global Data Sharing Initiative: A Federated 3-Layer Data Analysis Pipeline to Scale Up Multiple Sclerosis Research(2023)
Authors: Ashkan PIRMANI, Edward DE BROUWER, Lotte GEYS, Tina PARCIAK, Yves Moreau, Liesbet PEETERS
- Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-beta(2022)
Authors: Steve Simpson-Yap, Ashkan PIRMANI, Edward DE BROUWER, Liesbet PEETERS, Lotte GEYS, Tina PARCIAK, Anne Helme, Jan Hillert, Yves Moreau, Gilles Edan, et al.
- Updated Results of the COVID-19 in MS Global Data Sharing Initiative(2022)
Authors: Steve Simpson-Yap, Ashkan PIRMANI, Tomas Kalincik, Edward DE BROUWER, Lotte GEYS, Tina PARCIAK, Anne Helme, Nick Rijke, Jan A. Hillert, Yves Moreau, et al.
Pages: e200021 - Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis(2021)
Authors: Steve Simpson-Yap, Edward DE BROUWER, Tomas Kalincik, Nick Rijke, Jan A. Hillert, Clare Walton, Gilles Edan, Yves Moreau, Tim Spelman, Lotte GEYS, et al.
Pages: E1870 - E1885 - Updated results of the COVID-19 in MS global data sharing initiative validate consistent associations of anti-CD20 and other reported risk factors with severe COVID-19 outcomes(2021)
Authors: S. Simpson-Yap, Ashkan PIRMANI, Edward DE BROUWER, Lotte GEYS, Tina PARCIAK, A. Helme, N. Rijke, T. Kalincik, J. Hillert, Y. Moreau, et al.
Pages: 741 - 743 - Multiple Sclerosis Data Alliance - A global multi-stakeholder collaboration to scale-up real world data research(2021)
Authors: Liesbet PEETERS, Tina PARCIAK, Dipak Kalra, Yves Moreau, Elisabeth Kasilingam, Pieter van Galen, Christoph Thalheim, Bernard Uitdehaag, Patrick Vermersch, Niels HELLINGS, et al.
- The Multiple Sclerosis Data Alliance Catalogue; Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources(2021)
Authors: Lotte GEYS, Tina PARCIAK, Ashkan PIRMANI, Robert McBurney, Hollie Schmidt, Tanja MalbaĊĦa, Tjalf Ziemssen, Arnfin Bergmann, Juan I. Rojas, Edgardo Cristiano, et al.
Pages: 261 - 268 - COVID-19 in people with multiple sclerosis: A global data sharing initiative(2020)
Authors: Liesbet PEETERS, Tina PARCIAK, Clare Walton, Lotte GEYS, Yves Moreau, Edward DE BROUWER, Daniele Raimondi, Ashkan PIRMANI, Tomas Kalincik, Gilles Edan, et al.
Pages: 1157 - 1162 - First results of the COVID-19 in ms global data sharing initiative suggest anti-CD20 dmts are associated with worse covid-19 outcomes(2020)
Authors: S. Simpson-Yap, Edward DE BROUWER, T. Kalincik, N. Rijke, J. Hillert, C. Walton, G. Edan, Y. Moreau, T. Spelman, Lotte GEYS, et al.
Pages: 48 - 49